Overview of phase III trials on combined androgen treatment in patients with metastatic prostate cancer

Cancer. 1993 Dec 15;72(12 Suppl):3888-95. doi: 10.1002/1097-0142(19931215)72:12+<3888::aid-cncr2820721726>3.0.co;2-b.
No abstract available

Publication types

  • Meta-Analysis

MeSH terms

  • Androgen Antagonists / therapeutic use*
  • Antineoplastic Agents / therapeutic use*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Clinical Trials, Phase III as Topic
  • Combined Modality Therapy / trends
  • Humans
  • Male
  • Orchiectomy
  • Prognosis
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / surgery

Substances

  • Androgen Antagonists
  • Antineoplastic Agents